Comparing two minimally invasive heat treatments for early lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial compares two types of radiofrequency ablation (a heat-based treatment) for early-stage lung cancer that is located in the outer parts of the lung. One approach uses a needle through the chest wall, the other uses a bronchoscope through the airways. The goal is to see which works better for people who cannot have surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have a peripheral (outer part of the lung) lung cancer that is stage IA (small and hasn't spread).
- Surgery is not an option for you, or you choose not to have surgery.
- You are not taking blood thinners that cannot be paused for at least 5–7 days before the procedure.
- You do not have severe bleeding problems, serious lung scarring, uncontrolled infections, or other major health issues that would make the procedure unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to destroy early-stage lung cancer without surgery: one using a needle through the chest (CT-guided) and another using a thin tube through the mouth (bronchoscopy-guided). It might be an option if you have small, outer-edge lung cancer and cannot or prefer not to have surgery.
This trial tests a minimally invasive procedure using microwave energy to destroy small lung tumors, guided by a thin tube through the airways. It may be an option if you can't have standard surgery or radiation, or choose not to.
This trial tests a new treatment that uses short electrical pulses (pulsed electric field ablation) to destroy small lung tumors. It may be an option for people with limited, early-stage non-small cell lung cancer who can tolerate a minimally invasive procedure.
This study compares two minimally invasive treatments—bronchoscopic thermal vapor ablation (BTVA) and microwave ablation (MWA)—for people with COPD and early-stage lung cancer. Both treatments aim to destroy cancer cells without surgery, which may be a good option if you cannot or prefer not to have surgery.
This study looks at two ways to treat early-stage lung cancer: using heat from a tiny probe passed through the airways to kill the tumor (microwave ablation), or surgery to remove the tumor and some surrounding tissue. The goal is to find which approach is more effective and safer for people with this type of lung cancer.
This trial compares two ways to freeze and destroy small lung tumors: through the chest wall or through the airways. It’s for people with early-stage lung cancer who are not able or willing to have surgery.
Hear when a new Lung Cancer Stage IA trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.